Tevogen Bio announced up to $10 million in grant funding to enhance cancer and viral infection therapies and AI initiatives. Tevogen Bio, a clinical-stage biotech company focused on immunotherapy, ...

Systemic Bio, a subsidiary of 3D Systems, has been named a Top 10 Finalist for the SLAS 2025 Innovation Award, recognizing its innovative h-VIOS platform designed to enhance drug discovery through ...

Tevogen Bio’s ExacTcell platform creates off-the-shelf T-cell therapies targeting viral infections, cancers, and neurological conditions with scalable production from a single donor. The company ...

A series of announcements in recent weeks shows just how much the spatial biology field has matured in the years since Nature Methods recognized spatial biology—which it called spatially resolved ...